Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 373 entries
View as:

Study of Purified Vero Rabies Vaccine Compared With Two Reference Rabies Vaccines, Given in a Pre-exposure Regimen to Children and Adults and as Single Booster Dose to a Subset of Adults

Phase: N/A Priority: Normal
NCT ID: NCT04127786 Org: User:
Start: 10/21/19 End: 05/12/25 Due: 05/12/26

Study of Influenza Vaccine Revaccination in Healthy Adults Previously Vaccinated With Fluzone ID or Fluzone IM

Phase: N/A Priority: Normal
NCT ID: NCT01011049 Org: User:
Start: 09/30/09 End: 10/31/10 Due: 10/31/11

Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT01943825 Org: User:
Start: 11/05/13 End: 11/25/15 Due: 11/25/16

Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore

Phase: N/A Priority: Normal
NCT ID: NCT00880893 Org: User:
Start: 04/07/09 End: 10/14/14 Due: 10/14/15

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT04491877 Org: User:
Start: 09/17/20 End: 04/13/23 Due: 04/13/24

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

Phase: N/A Priority: Normal
NCT ID: NCT01230957 Org: User:
Start: 10/31/10 End: 03/31/13 Due: 03/31/14

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Phase: N/A Priority: Normal
NCT ID: NCT07013747 Org: User:
Start: 06/06/25 End: 07/12/29 Due: 07/12/30

Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America

Phase: N/A Priority: Normal
NCT ID: NCT01187433 Org: User:
Start: 08/31/10 End: 12/31/12 Due: 12/31/13

Immunology and Safety of Menactra® in Children in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT00539032 Org: User:
Start: 09/30/07 End: 02/28/09 Due: 02/28/10

Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01444781 Org: User:
Start: 09/30/11 End: 10/31/13 Due: 10/31/14

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00422292 Org: User:
Start: 12/31/06 End: 04/30/09 Due: 04/30/10

Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT06397768 Org: User:
Start: 05/13/24 End: 09/30/25 Due: 09/30/26

A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00384397 Org: User:
Start: 09/30/06 End: 02/28/09 Due: 02/28/10

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Phase: N/A Priority: Normal
NCT ID: NCT04551677 Org: User:
Start: 09/16/20 End: 12/18/20 Due: 12/18/21

Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults

Phase: N/A Priority: Normal
NCT ID: NCT02741128 Org: User:
Start: 11/06/19 End: 01/19/23 Due: 01/19/24

Burden of Respiratory Syncytial Virus (RSV) in Children in Sweden (BRICS): A Retrospective Study in Sweden

Phase: N/A Priority: Normal
NCT ID: NCT05622331 Org: User:
Start: 07/01/06 End: 04/19/24 Due: 04/19/25

Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to a Meningococcal Reference Vaccine, and When Given Alone or With Two Other Vaccines in Healthy Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT04490018 Org: User:
Start: 03/16/21 End: 05/11/22 Due: 05/11/23

Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)

Phase: N/A Priority: Normal
NCT ID: NCT04843111 Org: User:
Start: 03/05/21 End: 05/18/28 Due: 05/18/29

Safety and Immunogenicity of an Intramuscular A/H5N1 Inactivated, Split Virion Pandemic Influenza Vaccine in Children

Phase: N/A Priority: Normal
NCT ID: NCT00884182 Org: User:
Start: 04/30/09 End: 06/30/10 Due: 06/30/11

Cross-sectional Study to Assess Tolerability of the Trivalent Recombinant Vaccine in Individuals Between 18 and 64 Years Old Using the Vaccinees Perception of Injection

Phase: N/A Priority: Normal
NCT ID: NCT06765187 Org: User:
Start: 11/18/24 End: 01/04/25 Due: 01/04/26

Study of a Single Intramuscular Dose of Nirsevimab in the Prevention of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Infection in Healthy Term and Preterm Infants During the First Year of Life

Phase: N/A Priority: Normal
NCT ID: NCT05437510 Org: User:
Start: 08/08/22 End: 04/09/25 Due: 04/09/26

Study of Fluzone® Influenza Virus Vaccines 2012-2013 Formulation Among Adults.

Phase: N/A Priority: Normal
NCT ID: NCT01691339 Org: User:
Start: 09/30/12 End: 02/28/13 Due: 02/28/14

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US

Phase: N/A Priority: Normal
NCT ID: NCT03537508 Org: User:
Start: 04/25/18 End: 09/22/23 Due: 09/22/24

Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose, Influenza Vaccines in Adults

Phase: N/A Priority: Normal
NCT ID: NCT02258334 Org: User:
Start: 10/31/14 End: 12/31/14 Due: 12/31/15

Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA

Phase: N/A Priority: Normal
NCT ID: NCT04942210 Org: User:
Start: 07/01/21 End: 06/29/27 Due: 06/29/28